Zenas BioPharma Inc. trailing returns
How Zenas BioPharma Inc. (ZBIO) has performed over the last day, week, month and year and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +5.5% | +0.0% | +5.5% | — |
| 5 days | +12.0% | +0.0% | +12.0% | -2.2%Oct 16 |
| 1 month | -10.5% | +0.0% | -10.5% | -24.8%Oct 16 |
| YTD | -22.4% | +0.0% | -22.4% | -58.1%Jan 6 |
| 1 year | +7.8% | +0.0% | +7.8% | -64.8%Jan 2026 |
| Since inception (2024) | +23.3% | +0.0% | +23.3%+55.3% | -75.0%Jan 2025 |
Growth of ZBIO#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- Since inception (2024)+23.3%/year · +55.3%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in ZBIO's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Zenas BioPharma Inc.'s return since inception?
- Since 2024, Zenas BioPharma Inc. (ZBIO) has compounded at about +23.3% a year — +55.3% in total.